Practice
Featured experience
InSilico Medicine HK$2.62 billion IPO
We advised InSilico Medicine on its IPO and HKEX listing
Mastercard $1.8 billion acquisition of BVNK
We are advising Mastercard on the transaction
Sycamore Partners up to $23.7 billion acquisition of Walgreens Boots Alliance
We are advising Sycamore Partners on the transaction
Comcast spinoff of select cable television networks
We are advising Comcast on the transaction
Revolution Medicines $264.5 million follow-on offering
The shares are listed on Nasdaq
Bain Capital and ADIA acquisition of Merchants Fleet
We are advising Bain Capital and the consortium on the transaction
Morgan Stanley $4 billion senior notes offering
We advised Morgan Stanley on its SEC-registered global offering
Pon sale of its flow control businesses to MiddleGround Capital
We advised Pon on the transaction
Tailwind Capital acquisition of Onix Networking
We advised Tailwind Capital on the transaction
Deutsche Bank $1.3 billion senior notes offering
The fixed-to-floating-rate eligible liabilities notes are due 2026
Tuya global offering and dual primary listing on the Hong Kong Stock Exchange
We advised Tuya Inc. on its HK$141 million global offering and dual primary listing on the HKEX
Baker Hughes sale of Nexus Controls to GE Gas Power
We are advising Baker Hughes on the transaction
ChargePoint Holdings $500 million at-the-market offering
The common stock is listed on the New York Stock Exchange
NatWest Group $1 billion senior notes offering
We advised NatWest Group on the SEC-registered offering